195 related articles for article (PubMed ID: 31611960)
1. AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies.
Zhao SF; Wang SG; Zhao ZY; Li WL
Oncol Lett; 2019 Nov; 18(5):4515-4522. PubMed ID: 31611960
[TBL] [Abstract][Full Text] [Related]
2. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.
Penning TM; Burczynski ME; Jez JM; Hung CF; Lin HK; Ma H; Moore M; Palackal N; Ratnam K
Biochem J; 2000 Oct; 351(Pt 1):67-77. PubMed ID: 10998348
[TBL] [Abstract][Full Text] [Related]
3. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
4. Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily.
Steckelbroeck S; Oyesanmi B; Jin Y; Lee SH; Kloosterboer HJ; Penning TM
J Pharmacol Exp Ther; 2006 Mar; 316(3):1300-9. PubMed ID: 16339391
[TBL] [Abstract][Full Text] [Related]
5. Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells.
Chien CW; Ho IC; Lee TC
Carcinogenesis; 2009 Oct; 30(10):1813-20. PubMed ID: 19696165
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.
Huebbers CU; Verhees F; Poluschkin L; Olthof NC; Kolligs J; Siefer OG; Henfling M; Ramaekers FCS; Preuss SF; Beutner D; Seehawer J; Drebber U; Korkmaz Y; Lam WL; Vucic EA; Kremer B; Klussmann JP; Speel EM
Int J Cancer; 2019 May; 144(10):2465-2477. PubMed ID: 30367463
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Expression of
Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
[TBL] [Abstract][Full Text] [Related]
8. Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy.
Zeng CM; Chang LL; Ying MD; Cao J; He QJ; Zhu H; Yang B
Front Pharmacol; 2017; 8():119. PubMed ID: 28352233
[TBL] [Abstract][Full Text] [Related]
9. Long-chain fatty acids inhibit human members of the aldo-keto reductase 1C subfamily.
Hara A; Endo S; Matsunaga T; Soda M; Yashiro K; El-Kabbani O
J Biochem; 2017 Nov; 162(5):371-379. PubMed ID: 28992312
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human livers.
Amai K; Fukami T; Ichida H; Watanabe A; Nakano M; Watanabe K; Nakajima M
Drug Metab Pharmacokinet; 2020 Dec; 35(6):539-547. PubMed ID: 33036882
[TBL] [Abstract][Full Text] [Related]
12. New enzymatic assay for the AKR1C enzymes.
Beranič N; Stefane B; Brus B; Gobec S; Rižner TL
Chem Biol Interact; 2013 Feb; 202(1-3):204-9. PubMed ID: 23261716
[TBL] [Abstract][Full Text] [Related]
13. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics].
Li X; He J; Yu M; Zhang W; Sun J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of expression, prognostic significance and immune infiltration of RFC family genes in human sarcoma.
Wu G; Zhou J; Zhu X; Tang X; Liu J; Zhou Q; Chen Z; Liu T; Wang W; Xiao X; Wu T
Aging (Albany NY); 2022 Apr; 14(8):3705-3719. PubMed ID: 35483337
[TBL] [Abstract][Full Text] [Related]
15. The roles of aldo-keto reductases in steroid hormone action.
Bauman DR; Steckelbroeck S; Penning TM
Drug News Perspect; 2004 Nov; 17(9):563-78. PubMed ID: 15645014
[TBL] [Abstract][Full Text] [Related]
16. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.
Lin HY; Zeng D; Liang YK; Wei XL; Chen CF
Oncotarget; 2017 May; 8(21):34750-34761. PubMed ID: 28423734
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of the correlation between the expression of WFDC2 in B cells of lung adenocarcinoma tissue and the survival rate of patients].
Zhang H; Lu J; Yang Y; Wang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 May; 35(5):425-433. PubMed ID: 31223112
[TBL] [Abstract][Full Text] [Related]
18. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
19. Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid.
Steckelbroeck S; Jin Y; Oyesanmi B; Kloosterboer HJ; Penning TM
Mol Pharmacol; 2004 Dec; 66(6):1702-11. PubMed ID: 15383625
[TBL] [Abstract][Full Text] [Related]
20. Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
Wu Z; He L; Yang L; Fang X; Peng L
Front Mol Biosci; 2021; 8():651525. PubMed ID: 34513919
[No Abstract] [Full Text] [Related]
[Next] [New Search]